Second updated COVID booster dose OKd by FDA for at-risk individuals
Manjurul


The US FDA has authorized a second booster dose of the updated, bivalent COVID-19 vaccine for those 65 and older as well as immunocompromised individuals.
The authorization was granted to the manufacturers of the mRNA COVID vaccines, Moderna (NASDAQ:MRNA) and Pfizer (NYSE:PFE)/BioNTech (NASDAQ:BNTX).

The authorization is only for these two demographics. The FDA said it will wait on making a decision for additional vaccinations for others following an FDA advisory committee meeting in June on the shot's composition for the fall.
The FDA also said the bivalent vaccines are now authorized for those six months and older.
The agency added that the original Moderna (MRNA) and Pfizer (PFE)/BioNTech (BNTX) monovalent vaccines are no longer authorized and those wishing to be vaccinated can only receive the bivalent shots.
Read why Seeking Alpha contributor Paul Franke considers BioNTech (BNTX) undervalued.